[go: up one dir, main page]

ATE371652T1 - Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung - Google Patents

Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung

Info

Publication number
ATE371652T1
ATE371652T1 AT03735707T AT03735707T ATE371652T1 AT E371652 T1 ATE371652 T1 AT E371652T1 AT 03735707 T AT03735707 T AT 03735707T AT 03735707 T AT03735707 T AT 03735707T AT E371652 T1 ATE371652 T1 AT E371652T1
Authority
AT
Austria
Prior art keywords
broad
band
inhibiting effect
hiv protease
protease inhibiting
Prior art date
Application number
AT03735707T
Other languages
English (en)
Inventor
Dominique Surleraux
Bernhard Vergouwen
Kock Herman De
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Application granted granted Critical
Publication of ATE371652T1 publication Critical patent/ATE371652T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03735707T 2002-05-17 2003-05-16 Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung ATE371652T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02076957 2002-05-17

Publications (1)

Publication Number Publication Date
ATE371652T1 true ATE371652T1 (de) 2007-09-15

Family

ID=29433159

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03735707T ATE371652T1 (de) 2002-05-17 2003-05-16 Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung

Country Status (29)

Country Link
US (1) US7462636B2 (de)
EP (1) EP1517899B1 (de)
JP (2) JP4674084B2 (de)
KR (2) KR101019648B1 (de)
CN (1) CN100582097C (de)
AP (1) AP2004003190A0 (de)
AR (1) AR039887A1 (de)
AT (1) ATE371652T1 (de)
AU (1) AU2003238074B2 (de)
BR (1) BR0310089A (de)
CA (1) CA2485903C (de)
CY (1) CY1107040T1 (de)
DE (1) DE60315984T2 (de)
DK (1) DK1517899T3 (de)
EA (1) EA010908B1 (de)
ES (1) ES2292976T3 (de)
HK (1) HK1076099A1 (de)
HR (1) HRP20050607B1 (de)
IL (1) IL165043A0 (de)
MX (1) MXPA04011466A (de)
MY (1) MY135226A (de)
NO (1) NO330184B1 (de)
NZ (1) NZ536496A (de)
PL (1) PL373425A1 (de)
PT (1) PT1517899E (de)
SI (1) SI1517899T1 (de)
TW (1) TWI356700B (de)
WO (1) WO2003097616A1 (de)
ZA (1) ZA200410156B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04011466A (es) * 2002-05-17 2005-02-14 Tibotec Pharm Ltd Inhibidores de la proteasa de hiv de benzisoxazol sulfonamida sustituida de amplio espectro.
WO2005087728A1 (en) * 2004-03-11 2005-09-22 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
US7378441B2 (en) * 2004-05-07 2008-05-27 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
CA2595295C (en) 2005-02-25 2014-07-08 Tibotec Pharmaceuticals Ltd. Protease inhibitor precursor synthesis
CN101702908A (zh) * 2007-03-23 2010-05-05 麻萨诸塞州大学 Hiv-1蛋白酶抑制剂
JP2011515444A (ja) * 2008-03-25 2011-05-19 フォーマック ファーマシューティカルズ ナムローゼ フェンノートシャップ 固体分散体の調製方法
WO2011061590A1 (en) 2009-11-17 2011-05-26 Hetero Research Foundation Novel carboxamide derivatives as hiv inhibitors
DE102010004957A1 (de) * 2010-01-14 2011-07-21 Universitätsklinikum Jena, 07743 Biologisch wirksame Moleküle zur Beeinflussung von Virus-, Bakterien-, Parasiten-infizierten Zellen und/oder Tumorzellen und Verfahren zu deren Anwendung
US20150284380A1 (en) 2012-10-31 2015-10-08 Bayer Cropscience Ag Novel heterocyclic compounds as pest control agents
BR112015015846A2 (pt) * 2013-03-07 2017-07-11 Dow Global Technologies Llc éter de celulose esterificado, composição, dispersão sólida, forma de dosagem, invólucro de cápsula e processo para produzir um éter de celulose esterificado

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004751A (en) * 1987-08-28 1991-04-02 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
KR100336699B1 (ko) * 1992-08-25 2002-05-13 윌리암스 로저 에이 레트로바이러스 프로테아제 저해제로서 유용한히드록시에틸아미노 술폰아미드
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
ATE174587T1 (de) 1993-08-24 1999-01-15 Searle & Co Hydroxyaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
EP0721331B1 (de) 1993-10-01 2001-12-05 AstraZeneca AB Verfahren i
EP1586558A3 (de) * 1995-01-20 2005-10-26 G.D. Searle LLC. Bis-sulfonamid-hydroxyethylamino-Derivate als Inhibitoren retroviraler Proteasen
US5756533A (en) * 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5705500A (en) 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US6150556A (en) * 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
JP4124818B2 (ja) * 1995-03-10 2008-07-23 ジー．ディー．サール アンド カンパニー ヘテロシクロカルボニルアミノ酸ヒドロキシエチルアミノスルホンアミドレトロウイルスプロテアーゼインヒビター
EP0861249A1 (de) 1995-11-15 1998-09-02 G.D. Searle & Co. Substituierte sulfonylalkanoylamino-hydroxyethylamino-sulfonamide als hemmer von retroviraler protease
BR9706897B1 (pt) 1996-05-20 2010-09-21 forma de dosagem farmacêutica.
DK0969821T3 (da) 1997-03-26 2003-09-15 Janssen Pharmaceutica Nv Pellets, der har en kerne coatet med et antifungalt middel og en polymer
EA200000702A1 (ru) 1997-12-24 2000-12-25 Вертекс Фармасьютикалз Инкорпорейтед Пролекарства ингибиторов аспартилпротеаз
WO1999033792A2 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
AU2012199A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
DE69943266D1 (de) * 1998-06-23 2011-04-21 Trustees For The University Of Illinois Board Of Arzneimittel zur behandlung von hiv-infizierten säugetieren
WO1999067254A2 (en) 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
EP1222192B8 (de) 1999-10-06 2008-10-01 Tibotec Pharmaceuticals Ltd. Hexahydrofuro¬2,3-b furan-3-yl-n- 3-¬(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino -1-benzyl-2-hydroxypropyl carbamat als retrovirusproteasehemmer
HUP0303744A3 (en) * 2001-04-09 2008-03-28 Tibotec Pharm Ltd Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors and pharmaceutical compositions containing them
MXPA04011466A (es) * 2002-05-17 2005-02-14 Tibotec Pharm Ltd Inhibidores de la proteasa de hiv de benzisoxazol sulfonamida sustituida de amplio espectro.

Also Published As

Publication number Publication date
AR039887A1 (es) 2005-03-09
PL373425A1 (en) 2005-08-22
JP2011051999A (ja) 2011-03-17
HK1076099A1 (en) 2006-01-06
DE60315984T2 (de) 2008-05-29
JP2005527607A (ja) 2005-09-15
CN1668605A (zh) 2005-09-14
EA010908B1 (ru) 2008-12-30
KR20100130234A (ko) 2010-12-10
NZ536496A (en) 2006-06-30
TW200404538A (en) 2004-04-01
EP1517899A1 (de) 2005-03-30
AU2003238074A1 (en) 2003-12-02
SI1517899T1 (sl) 2008-02-29
HRP20050607A2 (en) 2006-02-28
ES2292976T3 (es) 2008-03-16
DK1517899T3 (da) 2007-12-03
PT1517899E (pt) 2007-11-16
NO330184B1 (no) 2011-02-28
JP4674084B2 (ja) 2011-04-20
WO2003097616A1 (en) 2003-11-27
DE60315984D1 (de) 2007-10-11
HRP20050607B1 (hr) 2014-07-04
CN100582097C (zh) 2010-01-20
CA2485903A1 (en) 2003-11-27
AP2004003190A0 (en) 2004-12-31
BR0310089A (pt) 2005-02-15
US7462636B2 (en) 2008-12-09
IL165043A0 (en) 2005-12-18
TWI356700B (en) 2012-01-21
CY1107040T1 (el) 2012-09-26
MXPA04011466A (es) 2005-02-14
CA2485903C (en) 2011-08-16
MY135226A (en) 2008-02-29
KR101019648B1 (ko) 2011-03-07
US20050171173A1 (en) 2005-08-04
ZA200410156B (en) 2005-11-30
EP1517899B1 (de) 2007-08-29
KR20050013549A (ko) 2005-02-04
EA200401524A1 (ru) 2005-06-30
AU2003238074B2 (en) 2009-04-30
NO20045444L (no) 2005-02-16

Similar Documents

Publication Publication Date Title
DE60311307D1 (de) Shampoo-zusammensetzungen
DE60322920D1 (de) Heterocyclische verbindungen mit hiv-integrase-hemmender wirkung
FI20020394A0 (fi) Valotutka
DK1501921T3 (da) Forbedrede virusrensningsmetoder
DK1660597T3 (da) Copolymer-tensider
DK1414803T3 (da) Pyrazolylcarboxanilider som fungicider
NL1021822A1 (nl) Tamsulosinetabletten.
NO20032613D0 (no) Farmasöytisk sammensetning som har en forbedret vannopplöselighet
NO20034949D0 (no) Sulfonamider
DE60235536D1 (de) Sulfonamidderivate
DE60215623D1 (de) Breitspektrum 2-(substituierte-amino)-benzothiazol-sulfonamide hiv protease inhibitoren
NO20052952D0 (no) Farmasoytisk sammensetning som innbefatter mikropartikler
NO20034695D0 (no) Nye sammensetninger
NO20042916L (no) HIV integrase inhibitorer
DE60316954D1 (de) Shampoozusammensetzungen
NO20040860L (no) Farmasoytisk sammensetning som innbefatter lumiracoxib
ATE371652T1 (de) Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung
DE60328353D1 (de) Schwungmasse
DK1387842T3 (da) Bredspektrede 2-amino-benzoxazolsulfonamid-HIV-protease-inhibitorer
BR0300119B1 (pt) composiÇço aquosa.
DE60322421D1 (de) Verbesserter brillenbügel
DK1556377T3 (da) Cyclopropylthienylcarboxamider som fungicider
DE602004027792D1 (de) Indazolamide mit analgetischer wirkung
NO20034505L (no) Bredspektret 2-(substituert-amino)-benzoxasolsulfonamid HIV proteasehemmere
DK1651047T3 (da) Herbicidekombinationer med specielle sulfonamider

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1517899

Country of ref document: EP